Trinity Biotech plc (TRIB)
USD 0.85
(6.99%)
USD 0.85
(6.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 83.38 Million USD | -11.56% |
| 2022 | 94.28 Million USD | -20.92% |
| 2021 | 119.21 Million USD | -10.11% |
| 2020 | 132.61 Million USD | 4.95% |
| 2019 | 126.35 Million USD | 17.89% |
| 2018 | 107.18 Million USD | -15.88% |
| 2017 | 127.41 Million USD | -9.55% |
| 2016 | 140.86 Million USD | -2.9% |
| 2015 | 145.07 Million USD | 216.3% |
| 2014 | 45.86 Million USD | 5.5% |
| 2013 | 43.47 Million USD | 55.12% |
| 2012 | 28.02 Million USD | 38.97% |
| 2011 | 20.16 Million USD | 2.96% |
| 2010 | 19.58 Million USD | -63.11% |
| 2009 | 53.1 Million USD | -16.51% |
| 2008 | 63.6 Million USD | -19.62% |
| 2007 | 79.13 Million USD | -3.34% |
| 2006 | 81.86 Million USD | 60.58% |
| 2005 | 50.98 Million USD | 46.97% |
| 2004 | 34.69 Million USD | -8.3% |
| 2003 | 37.82 Million USD | 43.51% |
| 2002 | 26.35 Million USD | 28.6% |
| 2001 | 20.49 Million USD | 68.18% |
| 2000 | 12.18 Million USD | -45.4% |
| 1999 | 22.32 Million USD | -26.58% |
| 1998 | 30.4 Million USD | 73.71% |
| 1997 | 17.5 Million USD | 525.0% |
| 1996 | 2.8 Million USD | 64.71% |
| 1995 | 1.7 Million USD | -5.56% |
| 1994 | 1.8 Million USD | 0.0% |
| 1993 | 1.8 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 123.75 Million USD | 9.36% |
| 2024 Q1 | 113.16 Million USD | 35.71% |
| 2023 Q1 | 97.77 Million USD | 3.71% |
| 2023 FY | 83.38 Million USD | -11.56% |
| 2023 Q4 | 83.38 Million USD | 2.84% |
| 2023 Q3 | 81.08 Million USD | -2.74% |
| 2023 Q2 | 83.37 Million USD | -14.73% |
| 2022 Q3 | 91.26 Million USD | -0.07% |
| 2022 Q2 | 91.32 Million USD | -18.74% |
| 2022 Q4 | 94.28 Million USD | 3.31% |
| 2022 FY | 94.28 Million USD | -20.92% |
| 2022 Q1 | 112.38 Million USD | -5.73% |
| 2021 Q1 | 136.1 Million USD | 2.63% |
| 2021 Q3 | 121.96 Million USD | -2.6% |
| 2021 Q4 | 119.21 Million USD | -2.26% |
| 2021 FY | 119.21 Million USD | -10.11% |
| 2021 Q2 | 125.22 Million USD | -8.0% |
| 2020 Q3 | 129 Million USD | -0.34% |
| 2020 Q1 | 128.35 Million USD | 1.58% |
| 2020 FY | 132.61 Million USD | 4.95% |
| 2020 Q2 | 129.44 Million USD | 0.84% |
| 2020 Q4 | 132.61 Million USD | 2.8% |
| 2019 FY | 126.35 Million USD | 17.89% |
| 2019 Q4 | 126.35 Million USD | -5.93% |
| 2019 Q3 | 134.32 Million USD | 1.27% |
| 2019 Q2 | 132.63 Million USD | 3.23% |
| 2019 Q1 | 128.47 Million USD | 19.87% |
| 2018 Q1 | 128.9 Million USD | 1.16% |
| 2018 Q2 | 127.75 Million USD | -0.89% |
| 2018 Q3 | 115.24 Million USD | -9.79% |
| 2018 Q4 | 107.18 Million USD | -7.0% |
| 2018 FY | 107.18 Million USD | -15.88% |
| 2017 Q1 | 135.86 Million USD | -3.55% |
| 2017 Q4 | 127.41 Million USD | -7.83% |
| 2017 Q2 | 137.93 Million USD | 1.52% |
| 2017 Q3 | 138.23 Million USD | 0.22% |
| 2017 FY | 127.41 Million USD | -9.55% |
| 2016 Q4 | 140.86 Million USD | -6.13% |
| 2016 Q1 | 147.56 Million USD | 1.72% |
| 2016 Q2 | 147.1 Million USD | -0.31% |
| 2016 Q3 | 150.06 Million USD | 2.01% |
| 2016 FY | 140.86 Million USD | -2.9% |
| 2015 Q1 | 45.53 Million USD | -0.72% |
| 2015 Q4 | 145.07 Million USD | 0.48% |
| 2015 FY | 145.07 Million USD | 216.3% |
| 2015 Q3 | 144.38 Million USD | -6.67% |
| 2015 Q2 | 154.7 Million USD | 239.74% |
| 2014 Q3 | 42.21 Million USD | -0.29% |
| 2014 Q1 | 39.9 Million USD | -8.21% |
| 2014 FY | 45.86 Million USD | 5.5% |
| 2014 Q2 | 42.34 Million USD | 6.11% |
| 2014 Q4 | 45.86 Million USD | 8.64% |
| 2013 Q1 | 28.77 Million USD | 2.68% |
| 2013 Q2 | 28.62 Million USD | -0.52% |
| 2013 FY | 43.47 Million USD | 55.12% |
| 2013 Q3 | 47.75 Million USD | 66.81% |
| 2013 Q4 | 43.47 Million USD | -8.95% |
| 2012 Q3 | 24.85 Million USD | 2.37% |
| 2012 Q4 | 28.02 Million USD | 12.78% |
| 2012 Q1 | 22.66 Million USD | 12.4% |
| 2012 Q2 | 24.27 Million USD | 7.09% |
| 2012 FY | 28.02 Million USD | 38.97% |
| 2011 Q2 | 20.94 Million USD | -0.68% |
| 2011 Q1 | 21.08 Million USD | 7.64% |
| 2011 Q4 | 20.16 Million USD | -1.82% |
| 2011 Q3 | 20.54 Million USD | -1.91% |
| 2011 FY | 20.16 Million USD | 2.96% |
| 2010 Q2 | 20.56 Million USD | -59.12% |
| 2010 Q1 | 50.3 Million USD | -5.26% |
| 2010 FY | 19.58 Million USD | -63.11% |
| 2010 Q4 | 19.58 Million USD | -7.78% |
| 2010 Q3 | 21.23 Million USD | 3.27% |
| 2009 Q4 | 53.1 Million USD | -1.96% |
| 2009 Q3 | 54.16 Million USD | -8.34% |
| 2009 FY | 53.1 Million USD | -16.51% |
| 2009 Q2 | 59.09 Million USD | 3.1% |
| 2009 Q1 | 57.31 Million USD | -9.89% |
| 2008 FY | 63.6 Million USD | -19.62% |
| 2008 Q3 | 67.84 Million USD | -2.35% |
| 2008 Q4 | 63.6 Million USD | -6.25% |
| 2008 Q2 | 69.47 Million USD | -6.33% |
| 2008 Q1 | 74.17 Million USD | -6.27% |
| 2007 Q4 | 79.13 Million USD | 0.0% |
| 2007 Q2 | 72.54 Million USD | -4.33% |
| 2007 FY | 79.13 Million USD | -3.34% |
| 2007 Q1 | 75.82 Million USD | -7.38% |
| 2006 Q1 | 43.13 Million USD | -15.39% |
| 2006 FY | 81.86 Million USD | 60.58% |
| 2006 Q4 | 81.86 Million USD | -0.85% |
| 2006 Q3 | 82.57 Million USD | -0.02% |
| 2006 Q2 | 82.58 Million USD | 91.46% |
| 2005 FY | 50.98 Million USD | 46.97% |
| 2005 Q2 | 33.79 Million USD | -2.16% |
| 2005 Q1 | 34.53 Million USD | -0.44% |
| 2005 Q4 | 50.98 Million USD | 9.58% |
| 2005 Q3 | 46.52 Million USD | 37.69% |
| 2004 FY | 34.69 Million USD | -8.3% |
| 2004 Q4 | 34.69 Million USD | -6.3% |
| 2004 Q3 | 37.02 Million USD | -2.88% |
| 2004 Q2 | 38.12 Million USD | -5.07% |
| 2004 Q1 | 40.15 Million USD | 6.15% |
| 2003 Q1 | 26.27 Million USD | -0.3% |
| 2003 Q2 | 21.25 Million USD | -19.11% |
| 2003 FY | 37.82 Million USD | 43.51% |
| 2003 Q3 | 39.43 Million USD | 85.51% |
| 2003 Q4 | 37.82 Million USD | -4.07% |
| 2002 Q3 | 20.47 Million USD | 10.11% |
| 2002 Q2 | 18.59 Million USD | -9.4% |
| 2002 Q4 | 26.35 Million USD | 28.72% |
| 2002 Q1 | 20.52 Million USD | 0.15% |
| 2002 FY | 26.35 Million USD | 28.6% |
| 2001 Q2 | 13.96 Million USD | 21.23% |
| 2001 Q1 | 11.51 Million USD | -5.52% |
| 2001 Q4 | 20.49 Million USD | 61.14% |
| 2001 FY | 20.49 Million USD | 68.18% |
| 2001 Q3 | 12.72 Million USD | -8.88% |
| 2000 Q1 | 21.94 Million USD | -1.69% |
| 2000 FY | 12.18 Million USD | -45.4% |
| 2000 Q4 | 12.18 Million USD | 11.12% |
| 2000 Q2 | 14.21 Million USD | -35.2% |
| 2000 Q3 | 10.96 Million USD | -22.86% |
| 1999 Q4 | 22.32 Million USD | -18.83% |
| 1999 Q3 | 27.5 Million USD | -8.03% |
| 1999 Q2 | 29.9 Million USD | 6.79% |
| 1999 Q1 | 28 Million USD | -7.89% |
| 1999 FY | 22.32 Million USD | -26.58% |
| 1998 Q3 | 29.8 Million USD | 63.74% |
| 1998 Q4 | 30.4 Million USD | 2.01% |
| 1998 Q2 | 18.2 Million USD | 0.0% |
| 1998 FY | 30.4 Million USD | 73.71% |
| 1997 FY | 17.5 Million USD | 525.0% |
| 1997 Q4 | 17.5 Million USD | 0.0% |
| 1996 Q4 | 2.8 Million USD | 0.0% |
| 1996 FY | 2.8 Million USD | 64.71% |
| 1995 Q4 | 1.7 Million USD | 0.0% |
| 1995 FY | 1.7 Million USD | -5.56% |
| 1994 FY | 1.8 Million USD | 0.0% |
| 1994 Q1 | 1.8 Million USD | 0.0% |
| 1993 FY | 1.8 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -107.289% |
| Biodesix, Inc. | 94.51 Million USD | 11.778% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -2377.024% |
| Castle Biosciences, Inc. | 86.54 Million USD | 3.649% |
| DarioHealth Corp. | 38.24 Million USD | -118.026% |
| Exact Sciences Corporation | 3.32 Billion USD | 97.493% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 95.303% |
| Illumina, Inc. | 4.36 Billion USD | 98.09% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -1390.152% |
| iSpecimen Inc. | 6.07 Million USD | -1271.885% |
| Standard BioTools Inc. | 159.86 Million USD | 47.841% |
| 23andMe Holding Co. | 206.64 Million USD | 59.649% |
| Medpace Holdings, Inc. | 1.09 Billion USD | 92.405% |
| NeoGenomics, Inc. | 739.69 Million USD | 88.727% |
| Inotiv, Inc. | 588.04 Million USD | 85.82% |
| Psychemedics Corporation | 6.59 Million USD | -1163.777% |
| Prenetics Global Limited | 44.01 Million USD | -89.452% |
| Precipio, Inc. | 3.67 Million USD | -2170.806% |
| RadNet, Inc. | 2.07 Billion USD | 95.978% |
| Sotera Health Company | 2.68 Billion USD | 96.896% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -284.701% |
| Exagen Inc. | 34.25 Million USD | -143.457% |
| Natera, Inc. | 691.79 Million USD | 87.947% |
| Aspira Women's Health Inc. | 8.62 Million USD | -866.547% |
| Neogen Corporation | 1.44 Billion USD | 94.21% |
| Myriad Genetics, Inc. | 312.9 Million USD | 73.351% |
| ICON Public Limited Company | 7.74 Billion USD | 98.924% |
| Bionano Genomics, Inc. | 118.24 Million USD | 29.483% |
| CareDx, Inc | 223.28 Million USD | 62.656% |
| Check-Cap Ltd. | 1.33 Million USD | -6169.474% |
| Twist Bioscience Corporation | 152.97 Million USD | 45.49% |
| Guardant Health, Inc. | 1.62 Billion USD | 94.877% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -4686.844% |
| Fulgent Genetics, Inc. | 139.82 Million USD | 40.365% |
| Sera Prognostics, Inc. | 25.28 Million USD | -229.803% |
| OPKO Health, Inc. | 622.47 Million USD | 86.605% |
| Personalis, Inc. | 95.65 Million USD | 12.831% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -849.794% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -284.701% |
| MDxHealth SA | 121.92 Million USD | 31.61% |
| Prenetics Global Limited | 44.01 Million USD | -89.452% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -7513.885% |
| Mainz Biomed B.V. | 12.15 Million USD | -585.735% |
| Neuronetics, Inc. | 81.64 Million USD | -2.135% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -2377.024% |